The stocks involved in the pharmaceutical industry in the record high price include Changchun Gaoxin, Gloria Ying, Aier Ophthalmology, Wuwu Bio, Opcom, Hengrui Pharma, Jimin Pharmaceutical, Antu Bio and Nanwei Medicine.

Let's talk about public offering first. According to the data of the third quarterly report, there are 19 companies in the bio-pharmaceutical industry that have increased their positions in the third quarter, among which WuXi PharmaTech Fund's shareholding in the tradable shares has increased the highest, rising by 3.28% to 8.66%. Look at social security funds, enterprise annuities and insurance companies. In the third quarter, there were 3 companies that held shares in total and accounted for an increase in the proportion of outstanding shares. Among them, the shareholding ratio of Dabo Medical was greatly increased from 5.6% to 13.73%.

The shareholding ratio of Lugutong has increased to 48, with Mindray Medical increasing the most, from 9.8% in the second quarter to 17.98%, while Yunnan Baiyao, Dabo Medical, Kangyuan Pharmaceutical and Gloria Ying all increased by more than 3%.

I'll take another picture. This is the ranking of stocks with net capital inflow from the north in October. Let's see how these tickets have risen since October. Is it a win? In fact, you don't have to go to great lengths to chase those hot topics every day. They all belong to zero-sum games, even negative zero-sum games, that is, I dig holes to bury you, and you dig holes to bury others, facing the harvest. However, compared with these hot money and short-term follow-up funds, large funds and foreign capital will be much more stable, and there will be no scenes of mutual harvest (after all, no one can cut anyone).

So what I want to share with you today is that you watch more "northbound funds" every day! Look at which sectors and which stocks the funds have flowed into, and follow it for a few months, and the feeling is slowly coming.